Patent · US Active

Bicyclic compound as a caspase inhibitor

US11434212B2 · kind B2 · utility

0Cited by

0References

20Claims

0Family size

Assignee

Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · CN

Inventors

Jianfeng Mou · Shanghai, CN
Songliang Wu · Shanghai, CN
Haiying He · Shanghai, CN
Fengying Guo · Shanghai, CN
Chuan Wang · Berkvam Road, US
Jie Li · Shanghai, CN
Jian Li · Shanghai, CN
Shuhui CHEN · Shanghai, CN

Key dates

Filing date	Jan 23, 2018
Grant date	Sep 6, 2022
Priority date	—
Expiry date	Nov 1, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D277/56
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

A compound represented by formula (I), a pharmaceutically acceptable salt or tautomer thereof, and an application of the compound as a caspase inhibitor.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.